EurekAlert! News by Subject: Medicine & Health

Medicine & Health

Updates every hour. Last Updated: 31-Oct-2026 07:15 ET (31-Oct-2026 11:15 GMT/UTC)

22-Sep-2026

Dr. Sunil Sharma, a top physician-scientist at HonorHealth Research Institute, is named ‘Arizona Bioscience Researcher of the Year’

HonorHealth Research Institute
Grant and Award Announcement

Sunil Sharma, M.D., FACP, M.B.A., director of the Center for Translational Science at HonorHealth Research Institute, has been named by the Arizona Bioindustry Association (AZBio) as the Arizona Bioscience Researcher of the Year.

22-Sep-2026

A plan to make veterans more visible for drug and alcohol care

Flinders University
Peer-Reviewed Publication

Many Australian veterans seek alcohol and other drug (AOD) care in mainstream services, where veteran status is not routinely identified – but Flinders University researchers present a solution to ensure that veterans with care needs are more visible and clearly recognised.

Journal: Drug and Alcohol Review

22-Sep-2026

NCI grant-funded study at Ohio State to focus on resistance to AML treatment in older adults

Ohio State University Wexner Medical Center
Grant and Award Announcement

A five-year, $3.46 million grant from the National Cancer Institute recently was awarded to The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute and the University of California San Francisco. The grant will help researchers study why some patients with acute myeloid leukemia respond to treatment while others don't. The findings could help doctors predict which patients will benefit from certain therapy before treatment even begins.

22-Sep-2026

KAIST finds a way to redirect cell fate with just a single stimulus

The Korea Advanced Institute of Science and Technology (KAIST)
Peer-Reviewed Publication

- Professor Kwang-Hyun Cho's team in the Department of Bio and Brain Engineering develops NUDGE, a general-purpose foundational technology that harnesses cells' own regulatory dynamics

- A single temporary intervention, without permanently altering genes, can switch cells between diverse states in computational models while preserving their native adaptability

- Expected to enable new control strategies spanning stem cell differentiation, aging, autoimmune disease, regenerative medicine, and cancer reversion therapy

Journal: Proceedings of the National Academy of Sciences
Funder: Ministry of Science and Information and Communication Technology, Korea Dementia Research Center, Ministry of Health & Welfare, Ministry of Science and ICT, Korea Advanced Institute of Science and Technology

22-Sep-2026

Higher UPF intake linked to heightened risk of multiple chronic health issues + death

BMJ Group
Peer-Reviewed Publication

A higher ultra processed food (UPF) intake is linked to a heightened risk of several major chronic health issues, such as digestive diseases, high blood pressure, and metabolic syndrome/diabetes, as well as death, finds a pooled data analysis of the available evidence, published in the open access journal Family Medicine and Community Health.

Journal: Family Medicine and Community Health
Funder: National Natural Science Foundation of China, Natural Science Foundation of Jiangxi Province, Jiangxi Province Thousands of Plan

22-Sep-2026

A shorter, better-tolerated treatment for chagas disease is possible

Barcelona Institute for Global Health (ISGlobal)
Peer-Reviewed Publication

A 30-day course of benznidazole taken once a day could offer people with chronic Trypanosoma cruzi infection a safer and more practical option than the current standard treatment, taken twice a day for 60 days. The TESEO trial, co-led by the Barcelona Institute for Global Health (ISGlobal), a center supported by the “la Caixa” Foundation, the University of Texas at El Paso (UTEP, USA), and CEADES (Bolivia), reports these results in The Lancet Infectious Diseases.

Journal: The Lancet Infectious Diseases

22-Sep-2026

Multicancer blood test detects 17 cancer types in large prospective study

Mayo Clinic
Peer-Reviewed Publication

A large prospective study published today in Nature Medicine found that a blood test designed to detect multiple cancers identified cancer signals across 17 broad cancer types, such as ovarian, lung, breast and colorectal cancers, and many which do not have recommended screening tests.

Journal: Nature Medicine
Funder: GRAIL Inc.

22-Sep-2026

PATHFINDER 2 findings advance multi-cancer early detection blood testing

Oregon Health & Science University
Peer-Reviewed Publication

A single blood draw that screens for more than 50 cancers substantially increased cancer detection when added to standard screening, identifying cancers that otherwise might have gone undetected until later stages, according to a new study from the Oregon Health & Science University Knight Cancer Institute.

The results from the PATHFINDER 2 study, published today in Nature Medicine, show the efficacy of GRAIL’s Galleri^® test, which uses a machine-learning algorithm to examine chemical patterns that distinguish cell-free DNA originating from healthy cells versus cancerous cells.

Journal: Nature Medicine
Funder: The study was designed and funded by GRAIL, Inc.

22-Sep-2026

C-Path’s Translational Therapeutics Accelerator awards $1.7 million across five bridge grants in brain health, pediatrics and rare diseases

Critical Path Institute (C-Path)
Grant and Award Announcement

Critical Path Institute today announced that its Translational Therapeutics Accelerator has awarded $1,699,500 through five Bridging Research and Innovation in Drug Development Grants (BRIDGe). Announced individually between March and July 2026, the projects address sepsis-related cognitive decline, inherited blindness, neurological lysosomal storage disease, pediatric cryptosporidiosis, and neuropathic pain.